STAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than Doubles - Has The Bull Case Changed?

Simply Wall St.04-15

STAAR Surgical Company reported preliminary net sales of over US$90,000,000 for the first quarter ended April 3, 2026, compared with US$42,600,000 a year earlier. This sharp year-on-year increase in ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2627470705?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-04-15 11:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2627470705","market":"hk","top_or_hot":-1,"title":"STAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than Doubles - Has The Bull Case Changed?","media":"Simply Wall St.","content":"<div>\n<p>STAAR Surgical Company reported preliminary net sales of over US$90,000,000 for the first quarter ended April 3, 2026, compared with US$42,600,000 a year earlier. This sharp year-on-year increase in ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/staar-surgical-staa-is-up-158-after-q1-revenue-more-than-dou\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>STAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than Doubles - Has The Bull Case Changed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSTAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than Doubles - Has The Bull Case Changed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-15 11:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/staar-surgical-staa-is-up-158-after-q1-revenue-more-than-dou><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>STAAR Surgical Company reported preliminary net sales of over US$90,000,000 for the first quarter ended April 3, 2026, compared with US$42,600,000 a year earlier. This sharp year-on-year increase in ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/staar-surgical-staa-is-up-158-after-q1-revenue-more-than-dou\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STAA","symbol_name":"STAAR Surgical Company","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/staar-surgical-staa-is-up-158-after-q1-revenue-more-than-dou","article_id":"2627470705","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/staar-surgical-staa-is-up-158-after-q1-revenue-more-than-dou","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2627470705","pubTimestamp":1776222669,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"STAAR Surgical Company reported preliminary net sales of over US$90,000,000 for the first quarter ended April 3, 2026, compared with US$42,600,000 a year earlier.\nThis sharp year-on-year increase in quarterly revenue highlights a significant step-change in the company’s recent commercial performance and operating momentum.\nWe’ll now examine how this sharp year-on-year revenue increase could reshape STAAR Surgical’s investment narrative and future business expectations.\nWe've uncovered the 12...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"STAA":"STAAR Surgical Company"},"translate_title":"STAAR Surgical(STAA)第一季度收入增长一倍多后上涨15.8%——牛市情况发生变化了吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1.5},"content_text":"STAAR Surgical Company reported preliminary net sales of over US$90,000,000 for the first quarter ended April 3, 2026, compared with US$42,600,000 a year earlier. This sharp year-on-year increase in quarterly revenue highlights a significant step-change in the company’s recent commercial performance and operating momentum. We’ll now examine how this sharp year-on-year revenue increase could reshape STAAR Surgical’s investment narrative and future business expectations. We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.AdvertisementSTAAR Surgical Investment Narrative RecapTo own STAAR Surgical, you need to believe its implantable lens franchise can turn strong procedure demand into sustainable, profitable growth despite recent losses and China volatility. The step-change to over US$90,000,000 in preliminary Q1 sales may sharpen focus on the near term catalyst of market adoption outside China, while also testing whether execution risks in China distribution and refractive demand are easing or simply being deferred. The recent FDA approval extending EVO/EVO+ lens use in the U.S. to patients aged 21 to 60 is especially relevant alongside the Q1 sales jump. Together, they put a spotlight on STAAR’s ability to broaden its addressable market and convert clinical interest into reliable revenue, even as investors weigh ongoing risks around China, competition, and the company’s still-loss making financial profile. But against that revenue surge, the unresolved issues around China distributor concentration and inventory levels are something investors should be aware of... Read the full narrative on STAAR Surgical (it's free!)STAAR Surgical's narrative projects $370.4 million revenue and $15.1 million earnings by 2028. This requires 18.2% yearly revenue growth and a $110.4 million earnings increase from -$95.3 million today.Uncover how STAAR Surgical's forecasts yield a $26.56 fair value, a 9% upside to its current price.Exploring Other PerspectivesSTAA 1-Year Stock Price Chart Some of the most optimistic analysts already expected revenue of about US$390,000,000 and earnings near US$52,000,000 by 2029, so this Q1 surprise could either reinforce that bullish growth story or expose how much depends on fragile assumptions about China resilience and long term ICL demand.Explore 2 other fair value estimates on STAAR Surgical - why the stock might be worth just $25.27!The Verdict Is YoursDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your STAAR Surgical research is our analysis highlighting 2 key rewards that could impact your investment decision.Our free STAAR Surgical research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate STAAR Surgical's overall financial health at a glance.Searching For A Fresh Perspective?Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.Outshine the giants: these 19 early-stage AI stocks could fund your retirement.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2627470705","isCrawlerRequest":true}